The silent microbial shift: climate change amplifies pathogen evolution, microbiome dysbiosis, and antimicrobial resistance
Tropical Diseases, Travel Medicine and Vaccines · Published 2025-11-13 · DOI 10.1186/s40794-025-00275-y
Free full text
Authors being retrieved — see the publisher record. https://doi.org/10.1186/s40794-025-00275-y
Abstract
Abstract Climate change is a primary driver of new infectious diseases. It affects pathogen evolution, vector ecology, and human susceptibility. Rising temperatures, changed rainfall patterns, and extreme weather events contributed to the spread of vector-borne, food-borne, and water-borne diseases. Furthermore, climate stressors promote antimicrobial resistance (AMR) and disrupt the human microbiome. This increases susceptibility to infections and chronic diseases. This review explores the complex relationships between climate change, microbial ecosystems, and public health focusing on how microbial dysbiosis and environmental changes interact to influence disease dynamics. We also highlight long-term solutions, such as One Health approaches, probiotics, and AI-powered early warning systems, as strategies for reducing future risks. Addressing these challenges requires global collaboration, climate-resilient health systems, and proactive actions to mitigate the health consequences of a rapidly changing environment.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →
Publication details
- Year
- 2025
Related articles
- Viruses help shape microbiome response to polyphenol rewiring of methane-suppressed peat microcosms · PLOS Biology · 2026 · Cites or is cited by this article
- Polymorphism of the dihydropteroate synthase resistance gene of Plasmodium falciparum in three hospitals in Mbouda, Western Cameroon · Tropical Diseases, Travel Medicine and Vaccines · 2025 · Same journal
- The global outbreak of Oropouche virus: surveillance of global trends · Tropical Diseases, Travel Medicine and Vaccines · 2026 · Same journal
- Rwanda’s National Reference Laboratory Operational Capacity during the 2024 Marburg Virus Disease Outbreak Response · Tropical Diseases, Travel Medicine and Vaccines · 2026 · Same journal
- Self-reported hepatitis B vaccination uptake and associated factors among adults in a tertiary hospital, Nasarawa State, Nigeria · Tropical Diseases, Travel Medicine and Vaccines · 2026 · Same journal
- Clinical, laboratory features and treatment outcomes of patients infected with Fasciola in Northern Vietnam, 2019–2023 · Tropical Diseases, Travel Medicine and Vaccines · 2025 · Same journal
- Safety of COVID-19 revaccination in patients with prior hypersensitivity reactions: a retrospective study · Tropical Diseases, Travel Medicine and Vaccines · 2025 · Same journal
- Furuncular cutaneous myiasis after travel in South America: case report and epidemiologic, diagnostic and management considerations · Tropical Diseases, Travel Medicine and Vaccines · 2025 · Same journal
- Integrated strategies for controlling and eliminating Neglected Tropical Diseases in Sub-Saharan Africa: a review of approaches, challenges, and opportunities · Tropical Diseases, Travel Medicine and Vaccines · 2026 · Same journal
- Integrated assessment of malaria parasite load, anemia, and associated factors in patients with and without soil-transmitted helminthes coinfection in Southern Ethiopia · Tropical Diseases, Travel Medicine and Vaccines · 2025 · Same journal